3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
7
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Mesothelioma, Malignant
4
Urethral Neoplasms
3
Small Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Solitary Fibrous Tumor, Pleural
1
Sertoli-Leydig Cell Tumor
1
Interventions
Rituximab
5
Valganciclovir
2
Methotrexate
2
Leucovorin
2
Doxorubicin
2
valomaciclovir
1
threonic acid
1
pembrolizumab
1
otelixizumab
1
merphos
1
cc-486
1
avelumab
1
Zidovudine
1
Vincristine
1
Valacyclovir
1
Tomography, X-Ray Computed
1
Prednisone
1
Magnesium Sulfate
1
Interferons
1
Hydroxyurea
1
Etoposide
1
Echocardiography
1
EPOCH protocol
1
Cyclophosphamide
1
Caves
1
Carboplatin
1
Brentuximab Vedotin
1
Bortezomib
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Epstein-Barr Virus Infections
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
No trials found.